Pharmafile Logo
Pharmafocus logo
Advanced Search

Galvus

Showing 4 posts of 4 posts found.

Biocon image

Novartis sues Biocon

April 4, 2014
Sales and Marketing Biocon, Galvus, Gilead, Herceptin, Novartis, sofosbuvir

India’s status as a battleground for patent issues has been reinforced with the news that Novartis is suing Biocon over …

News
Lucentis image

Lucentis approved in China

January 18, 2012
Sales and Marketing China, Galvus, Lucentis, Novartis, em, emerging markets

Novartis’ eye treatment Lucentis has gained approval in China, and the firm has also launched its diabetes drug Galvus in …

News

Triple approval for Novartis in Japan

January 20, 2010
Sales and Marketing Afinitor, Asia, Exforge, Galvus, Japan, Novartis, hypertension

Japanese regulators have approved three new Novartis medicines for use patients with type II diabetes, high blood pressure and advanced …

News

Surprise delay for Novartis’ Galvus

November 15, 2006
Sales and Marketing Galvus, diabetes

The FDA will take three months longer than expected to review Novartis' new diabetes treatment, Galvus, after the pharma company …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026